- An antibody, or protein, that stops proprotein convertase subtilisin-kexin type 9 is called PCSK9. This results in an increased longevity of the receptors in cells that pull LDL-C out of the blood stream. Because these receptors are now able to last longer, they are able to pull more LDL-C out of the blood stream and lower your cholesterol. LEARN MORE
- PCSK9 Inhibitors have been proven to lower LDL-C levels even in patients who do not respond to existing cholesterol lowering statins. LEARN MORE
- PCSK9 Inhibitors are taken once every 2 weeks or once monthly.
